Role of Narrow Band Imaging in Management of Urothelial Carcinoma
- 286 Downloads
Urothelial carcinoma of the bladder and upper tract is primarily diagnosed by white light endoscopy, which has well-known limitations that contribute to the increased risk of tumor recurrence and progression. Narrow band imaging (NBI) is an optical imaging technology that facilitates detection of tumor vasculature and differentiation of benign urothelium from neoplastic tissue. For urothelial carcinoma, NBI may be utilized in a variety of clinical settings, including office cystoscopy for initial identification and surveillance, transurethral resection for pathological diagnosis, and ureteroscopic management of upper tract lesions. Early evidence suggests that NBI increases the detection of urothelial carcinoma in the bladder and upper tract, including flat high-grade lesions such as carcinoma-in-situ that are a diagnostic challenge under white light. NBI also appears to improve the quality of transurethral resection and thereby reduce the frequency of tumor recurrence.
KeywordsNarrow band imaging Urothelial carcinoma White light cystoscopy Diagnostic ureteroscopy Transurethral resection
Compliance with Ethics Guidelines
Conflict of Interest
The authors declare that they have no competing interests.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance
- 3.Roupret M, Zigeuner R, Palou J, Boehle A, Kaasinen E, Sylvester R, et al. European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update. European Association of Urology Guideline Group for urothelial cell carcinoma of the upper urinary tract. Actas Urol Esp. 2012;36(1):2–14. doi: 10.1016/j.acuro.2011.09.001.PubMedCrossRefGoogle Scholar
- 6.Sylvester RJ, van der Meijden AP, Oosterlinck W, Witjes JA, Bouffioux C, Denis L, et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol. 2006;49(3):466–5. doi: 10.1016/j.eururo.2005.12.031. discussion 75–7.PubMedCrossRefGoogle Scholar
- 8.Fradet Y, Grossman HB, Gomella L, Lerner S, Cookson M, Albala D, et al. A comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in situ in patients with bladder cancer: a phase III, multicenter study. J Urol. 2007;178(1):68–73. doi: 10.1016/j.juro.2007.03.028. discussion.PubMedCrossRefGoogle Scholar
- 9.Jocham D, Witjes F, Wagner S, Zeylemaker B, van Moorselaar J, Grimm MO, et al. Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: a prospective, phase III multicenter study. J Urol. 2005;174(3):862–6. doi: 10.1097/01.ju.0000169257.19841.2a. discussion 6.PubMedCrossRefGoogle Scholar
- 12.Daniltchenko DI, Riedl CR, Sachs MD, Koenig F, Daha KL, Pflueger H, et al. Long-term benefit of 5-aminolevulinic acid fluorescence assisted transurethral resection of superficial bladder cancer: 5-year results of a prospective randomized study. J Urol. 2005;174(6):2129–33. doi: 10.1097/01.ju.0000181814.73466.14. discussion 33.PubMedCrossRefGoogle Scholar
- 13.Cheng L, Neumann RM, Weaver AL, Cheville JC, Leibovich BC, Ramnani DM, et al. Grading and staging of bladder carcinoma in transurethral resection specimens. Correlation with 105 matched cystectomy specimens. Am J Clin Pathol. 2000;113(2):275–9. doi: 10.1309/94b6-8vfb-mn9j-1nf5.PubMedCrossRefGoogle Scholar
- 24.Zheng C, Lv Y, Zhong Q, Wang R, Jiang Q. Narrow band imaging diagnosis of bladder cancer: systematic review and meta-analysis. BJU Int. 2012;110(11 Pt B):E680-7. doi: 10.1111/j.1464-410X.2012.11500.x.
- 26.Geavlete B, Multescu R, Georgescu D, Stanescu F, Jecu M, Geavlete P. Narrow band imaging cystoscopy and bipolar plasma vaporization for large nonmuscle-invasive bladder tumors—results of a prospective, randomized comparison to the standard approach. Urology. 2012;79(4):846–51. doi: 10.1016/j.urology.2011.08.081.PubMedCrossRefGoogle Scholar
- 28.•Naselli A, Introini C, Timossi L, Spina B, Fontana V, Pezzi R, et al. A randomized prospective trial to assess the impact of transurethral resection in narrow band imaging modality on non-muscle-invasive bladder cancer recurrence. Eur Urol. 2012;61(5):908–13. doi: 10.1016/j.eururo.2012.01.018. This randomized prospective trial assessed the impact of NBI on 1-year bladder cancer recurrence risk and found that TUR performed under NBI significantly reduced recurrence risk in comparison to WLC. PubMedCrossRefGoogle Scholar
- 29.•Herr HW. Randomized trial of narrow-band versus white-light cystoscopy for restaging (second-look) transurethral resection of bladder tumors. Eur Urol. 2014. doi: 10.1016/j.eururo.2014.06.049. This randomized controlled trial showed that NBI-assisted TUR of bladder tumors significantly reduced the recurrence rate and improved recurrence-free survival when compared to WLC-assisted TUR. Google Scholar
- 31.•Naito S, van Rees Vellinga S, de la Rosette J. Global randomized narrow band imaging versus white light study in nonmuscle invasive bladder cancer: accession to the first milestone-enrollment of 600 patients. J Endourol / Endourol Soc. 2013;27(1):1–3. doi: 10.1089/end.2012.1556. This is an update on the international multicenter randomized controlled trial launched in 2010 with the aim to compare the recurrence rate at 1 year after NBI- and WLC-assisted TUR in patients with non-muscle-invasive bladder cancer. The study includes 24 centers and is nearing completion of goal enrollment of 1000 patients. CrossRefGoogle Scholar
- 39.Lapini A, Minervini A, Masala A, Schips L, Pycha A, Cindolo L, et al. A comparison of hexaminolevulinate (Hexvix((R))) fluorescence cystoscopy and white-light cystoscopy for detection of bladder cancer: results of the HeRo observational study. Surg Endosc. 2012;26(12):3634–41. doi: 10.1007/s00464-012-2387-0.PubMedCrossRefGoogle Scholar
- 40.Rink M, Babjuk M, Catto JW, Jichlinski P, Shariat SF, Stenzl A, et al. Hexyl aminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: a critical review of the current literature. Eur Urol. 2013;64(4):624–38. doi: 10.1016/j.eururo.2013.07.007.PubMedCrossRefGoogle Scholar
- 41.Kausch I, Sommerauer M, Montorsi F, Stenzl A, Jacqmin D, Jichlinski P, et al. Photodynamic diagnosis in non-muscle-invasive bladder cancer: a systematic review and cumulative analysis of prospective studies. Eur Urol. 2010;57(4):595–606. doi: 10.1016/j.eururo.2009.11.041.PubMedCrossRefGoogle Scholar
- 43.Chang TC, Liu JJ, Liao JC. Probe-based confocal laser endomicroscopy of the urinary tract: the technique. J Vis Exp JoVE. 2013;(71):e4409. doi: 10.3791/4409.
- 47.Hermes B, Spoler F, Naami A, Bornemann J, Forst M, Grosse J, et al. Visualization of the basement membrane zone of the bladder by optical coherence tomography: feasibility of noninvasive evaluation of tumor invasion. Urology. 2008;72(3):677–81. doi: 10.1016/j.urology.2008.02.062.PubMedCrossRefGoogle Scholar
- 50.Matin SF, Kamat AM, Grossman HB. High-frequency endoluminal ultrasonography as an aid to the staging of upper tract urothelial carcinoma: imaging findings and pathologic correlation. J Ultrasound Med Offic J Am Instit Ultrasound Med. 2010;29(9):1277–84.Google Scholar